title: Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.
abstract: Mast cells (MCs) are well-known effectors of allergic reactions and are considered sentinels in the skin and mucosa. In addition, through their production of cathelicidin, MCs have the capacity to oppose invading pathogens. We therefore hypothesized that MCs could act as sentinels in the skin against viral infections using antimicrobial peptides. In this study, we demonstrate that MCs react to vaccinia virus (VV) and degranulate using a membrane-activated pathway that leads to antimicrobial peptide discharge and virus inactivation. This finding was supported using a mouse model of viral infection. MC-deficient (Kit(wsh-/-)) mice were more susceptible to skin VV infection than the wild type animals, whereas Kit(wsh-/-) mice reconstituted with MCs in the skin showed a normal response to VV. Using MCs derived from mice deficient in cathelicidin antimicrobial peptide, we showed that antimicrobial peptides are one important antiviral granule component in in vivo skin infections. In conclusion, we demonstrate that MC presence protects mice from VV skin infection, MC degranulation is required for protecting mice from VV, neutralizing Ab to the L1 fusion entry protein of VV inhibits degranulation apparently by preventing S1PR2 activation by viral membrane lipids, and antimicrobial peptide release from MC granules is necessary to inactivate VV infectivity.
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
authors.forename: Zhenping
authors.initials: Z
authors.lastname: Wang
authors.forename: Yuping
authors.initials: Y
authors.lastname: Lai
authors.forename: Jamie J
authors.initials: JJ
authors.lastname: Bernard
authors.forename: Daniel T
authors.initials: DT
authors.lastname: Macleod
authors.forename: Anna L
authors.initials: AL
authors.lastname: Cogen
authors.forename: Bernard
authors.initials: B
authors.lastname: Moss
authors.forename: Anna
authors.initials: A
authors.lastname: Di Nardo
mesh_terms: D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D015550:Cell Degranulation / Q000235:genetics / Q000276:immunology*; D007113:Immunity, Innate / Q000502:physiology; D008407:Mast Cells / Q000276:immunology* / Q000378:metabolism / Q000821:virology; D051379:Mice; D018345:Mice, Knockout; D049349:Receptors, Lysosphingolipid / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D012867:Skin / Q000276:immunology* / Q000378:metabolism / Q000821:virology; D017193:Skin Diseases, Viral / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D000081025:Sphingosine-1-Phosphate Receptors; D014615:Vaccinia / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D014616:Vaccinia virus / Q000276:immunology* / Q000378:metabolism; D038301:Virus Inactivation; D054804:Cathelicidins
chemical_list: D023181:Antimicrobial Cationic Peptides; D049349:Receptors, Lysosphingolipid; D000081025:Sphingosine-1-Phosphate Receptors; C533955:sphingosine-1-phosphate receptor-2, mouse; D054804:Cathelicidins